Kolanczyk Denise M, Merlo Jessica R, Bradley Bridget, Flannery Alexander H, Gibson Caitlin M, McBane Sarah, Murphy Julie A, Noble Jacob M, Noble Melissa B, Patton Hunter M, Rosselli Jennifer L, Stone Rebecca H, Thornby Krisy-Ann
American College of Clinical Pharmacy, 13000, W. 87th St. Parkway, Suite 100, Lenexa, KS, 66215-4530, USA.
J Am Coll Clin Pharm. 2024 Mar;7(3):255-269. doi: 10.1002/jac5.1930. Epub 2024 Feb 29.
The American College of Clinical Pharmacy (ACCP) Pharmacotherapy Didactic Curriculum Toolkit has been used by colleges and schools of pharmacy as a guide for curricular development and revisions since its inaugural publication in 2009. The toolkit was last revised and updated by the 2019 Publications Committee.
The 2023 ACCP Publications Committee was charged with reviewing the 2019 Update to the ACCP Pharmacotherapy Didactic Curriculum Toolkit to determine any necessary revisions/updates.
The committee revised tier classifications, shifting the focus of the 2023 toolkit to content within the Pharm.D. curriculum. Multiple literature sources were reviewed to assess conditions for inclusion in the 2023 toolkit, and external feedback was solicited from various practice disciplines. All topics were voted on by a simple majority rule during virtual meetings or by electronic votes.
There are a total of 231 topics in the 2023 toolkit, a decrease of 77 (23.2%) from the 2019 edition. Topics in each tier are as follows: 68 as tier 1 (29%), 111 as tier 2 (48%), and 52 as tier 3 (23%). Although some topics were removed completely, others were combined with other line items or revised, which may further minimize curricular overload. Similar to the 2016 and 2019 toolkits, many tier 2 topics remain in the 2023 toolkit, emphasizing the continued need for additional training through postgraduate residencies or fellowships (or "on-the-job" equivalent experiences), board certifications, and various certificate training programs.
The 2023 ACCP Pharmacotherapy Didactic Curriculum Toolkit is designed to assist individual faculty and colleges and schools of pharmacy with curricular development and revisions. It will continue to be reviewed every 3 years to identify needed revisions on the basis of the pharmacist's evolving role, advances in therapeutics and pharmacy practice, and changes to accreditation standards and recognized professional competencies.
自2009年首次出版以来，美国临床药学院（ACCP）的药物治疗教学课程工具包一直被药学院校用作课程开发和修订的指南。该工具包上次由2019年出版委员会进行修订和更新。
2023年ACCP出版委员会负责审查《ACCP药物治疗教学课程工具包2019年更新版》，以确定任何必要的修订/更新。
委员会修订了层级分类，将2023年工具包的重点转移到药学博士课程中的内容。审查了多个文献来源，以评估纳入2023年工具包的条件，并征求了各实践学科的外部反馈。所有主题在虚拟会议期间或通过电子投票以简单多数规则进行表决。
2023年工具包共有231个主题，比2019年版减少了77个（23.2%）。各层级的主题如下：68个为一级主题（29%），111个为二级主题（48%），52个为三级主题（23%）。虽然一些主题被完全删除，但其他主题与其他项目合并或修订了，这可能进一步减少课程负担。与2016年和2019年工具包类似，许多二级主题仍保留在2023年工具包中，强调通过研究生住院医师培训或奖学金（或“在职”等效经验）、委员会认证和各种证书培训项目继续进行额外培训的必要性。
2023年ACCP药物治疗教学课程工具包旨在协助各院校的教师以及药学院校进行课程开发和修订。它将继续每3年进行一次审查，以根据药剂师不断演变的角色、治疗学和药学实践的进展以及认证标准和公认专业能力的变化确定所需的修订。
